Standard BioTools Inc.

NASDAQ (USD): Standard BioTools Inc. (FLDM)

Last Price

3.71

Today's Change

-0.28 (7.01%)

Day's Change

3.66 - 3.99

Trading Volume

522,109

Overview

Market Cap

294 Million

Shares Outstanding

79 Million

Avg Volume

956,988

Avg Price (50 Days)

3.63

Avg Price (200 Days)

4.86

PE Ratio

-4.74

EPS

-0.78

Earnings Announcement

04-May-2022

Previous Close

3.99

Open

4.05

Day's Range

3.66 - 3.99

Year Range

2.67 - 7.51

Trading Volume

522,109

Price Change Highlight

1 Day Change

0.00%

5 Day Change

0.00%

1 Month Change

0.00%

3 Month Change

0.00%

6 Month Change

0.00%

Ytd Change

0.00%

1 Year Change

5.70%

3 Year Change

6.92%

5 Year Change

-45.76%

10 Year Change

-77.77%

Max Change

-73.54%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Diagnostics & Research

Description:

Fluidigm Corporation creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar reagents, Maxpar direct immune profiling assays, Maxpar on demand reagents, and IMC panel kits for immuno-oncology. The company also provides preparatory instruments, such as Juno systems; and analytical instruments comprising Biomark HD system and EP1 system. In addition, it offers integrated fluidic circuits (IFCs), such as library preparation IFCs, Juno genotyping IFC, dynamic array IFCs, digital array IFCs, and Flex Six IFC; and assays and reagents, including Advanta RNA-Seq NGS library prep kits, Advanta Dx SARS-CoV-2 RT-PCR assays, Advanta Dx COVID-19 EASE assays, delta gene and SNP type assays, access array target-specific primers and targeted sequencing prep primers, and targeted DNA Seq library assays. Further, the company offers single cell microfluidics that comprise C1 systems; preparatory analytical instruments, which include C1 IFCs; and software solutions. It sells its products to academic research institutions; translational research and medicine centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology, and plant and animal research companies; and contract research organizations. Fluidigm Corporation has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Mycometrix Corporation and changed its name to Fluidigm Corporation in April 2001. Fluidigm Corporation was incorporated in 1999 and is headquartered in South San Francisco, California.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment